Cerebrolysin (60mg) Dosage Protocol
Cerebrolysin is a peptide preparation derived from porcine brain tissue containing low molecular weight neuropeptides and free amino acids. It has been studied for neurotrophic and neuroprotective properties.
Pre-mixed solution - no reconstitution needed
10-30 mL IV or IM daily for clinical protocols
Ampules typically 5-10 mL each
Store at 2-8°C, protected from light
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Mild protocols | 5-10 mL daily | IM injection |
| Standard protocols | 10-30 mL daily | IV infusion |
| Duration | 10-20 days | Per treatment course |
- 1Cerebrolysin comes as ready-to-use solution
- 2For IV: dilute in 100-250 mL saline
- 3Infuse slowly over 15-60 minutes
- 4For IM: inject undiluted into muscle
Cerebrolysin contains neurotrophic factors that mimic the action of endogenous growth factors like NGF and BDNF. Research suggests it may support neuroplasticity, protect neurons from damage, and enhance cognitive function through multiple mechanisms.
- Neurotrophic factor activity
- Research in stroke recovery
- Studied for cognitive enhancement
- May support neuroplasticity
- Plosker GL, Gauthier S. Cerebrolysin: a review. Drugs Aging. 2009
- Chen CC, et al. Cerebrolysin for acute ischaemic stroke. Cochrane Database. 2017
- Cerebrolysin neurotrophic research studies
Lyophilized
N/A - liquid formulation
Reconstituted
N/A - ready to use
Store refrigerated, protect from light, do not freeze
- •Approved in some countries for neurological conditions
- •Requires medical supervision
- •IV administration needs proper training
- •Not FDA approved in the United States
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.